Efficacy and Safety of Cobiprostone in Patients With Portal Hypertension

Summary

The primary purpose of this study is to determine the efficacy and safety of cobiprostone (at two dose levels) as compared to placebo for lowering portal hypertension.

Timeline

Start

2008-07

Primary completion

2009-02

Completion

2009-03

Outcome

Outcome not reported

Stopped (Enrollment): “Failure to enroll a suitable number of qualified subjects.”

Drugs

Indications